Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Carbamylation of amino and tyrosine hydroxyl groups. Preparation of an inhibitor of oxytocin with no intrinsic activity on the isolated uterus.

Literature DB >> 6067157

Carbamylation of amino and tyrosine hydroxyl groups. Preparation of an inhibitor of oxytocin with no intrinsic activity on the isolated uterus.

D G Smyth.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1967 PMID： 6067157

Source DB: PubMed Journal: J Biol Chem ISSN： 0021-9258 Impact factor: 5.157

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Site-Specific Detection and Characterization of Ubiquitin Carbamylation.

Authors: Westley Pawloski; Teppei Komiyama; Christos Kougentakis; Ananya Majumdar; David Fushman
Journal: Biochemistry Date: 2022-04-05 Impact factor: 3.321

Review 2. Avenues for post-translational protein modification prevention and therapy.

Authors: Mengyao Tang; Sahir Kalim
Journal: Mol Aspects Med Date: 2022-02-25

3. The binding of carbon dioxide by horse haemoglobin.

Authors: J V Kilmartin; L Rossi-Bernardi
Journal: Biochem J Date: 1971-08 Impact factor: 3.857

4. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.

Authors: Sahir Kalim; Caitlin A Trottier; Julia B Wenger; Josh Wibecan; Rayhnuma Ahmed; Elizabeth Ankers; S Ananth Karumanchi; Ravi Thadhani; Anders H Berg
Journal: Clin J Am Soc Nephrol Date: 2016-07-21 Impact factor: 8.237

5. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.

Authors: G W Bisset; B J Clark; I Krejcí; I Polácek; J Rudinger
Journal: Br J Pharmacol Date: 1970-10 Impact factor: 8.739

Carbamylation of amino and tyrosine hydroxyl groups. Preparation of an inhibitor of oxytocin with no intrinsic activity on the isolated uterus.

1. Site-Specific Detection and Characterization of Ubiquitin Carbamylation.

Review 2. Avenues for post-translational protein modification prevention and therapy.

3. The binding of carbon dioxide by horse haemoglobin.

4. Longitudinal Changes in Protein Carbamylation and Mortality Risk after Initiation of Hemodialysis.

5. Some pharmacological properties of a synthetic oxytocin analogue [1-N-carbamoyl-hemicystine-2-O-methyltyrosine]-oxytocin (carbamoyl-methyloxytocin), an antagonist to the neurohypophysial hormones.

Review 6. The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.

Review 7. Carbamylated Proteins in Renal Disease: Aggravating Factors or Just Biomarkers?

Review 8. Protein carbamylation in kidney disease: pathogenesis and clinical implications.

9. Evalution of in vitro effect of flavonoids on human low-density lipoprotein carbamylation.